NEW YORK (GenomeWeb) – Great Basin Scientific has submitted a molecular panel assay for stool pathogens to the US Food and Drug Administration for 510(k) clearance.

The panel detects Salmonella species, Shigella species, Shiga Toxin-producing E. coli (stx1, stx 2, and O157 serotype-specific genes), and Campylobacter species (C. jejuni and C. coli) from stool samples. It requires less than two minutes of hands-on time and has a turnaround time of under two hours, the company said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jul
24
Sponsored by
Qiagen

In this webinar, Dr. Fergus Couch from the Mayo Clinic will present data from a large study that used a targeted sequencing panel to determine pancreatic cancer risk associated with inherited mutations in several cancer predisposition genes.

Jul
25
Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms. 

Aug
09

In this two-part webinar, Dr. Elin Gray, from Edith Cowan University, and Ms. Weiwei Zhao, from Kingmed diagnostic, will compare the highly sensitive, multiplexed UltraSEEK technology, on the MassARRAY system, to digital droplet PCR (ddPCR) results on melanoma and non-small cell lung carcinoma samples.